Comparison of three-fold converted hematocrit and micro-hematocrit in pregnant women

Abstract

Background Anemia is one of the common complications of pregnancy. Hemoglobin concentration, Hematocrit, and Red cell count are laboratory tests used to diagnose anemia. In are source poor setting, there is a practice of using three-fold converted Hematocrit. This study is designed to assess the association and acceptability of three-fold converted Hematocrit as compared to the standard Micro-hematocrit method, in pregnant women. Method The cross-sectional study conducted from May 18 to June 12, 2018 involved 200 pregnant women who visited the Laboratory for a Hematocrit test. Three milliliter of venous blood was collected with EDTA tube to determine Hematocrit by the Micro-hematocrit method and Hemoglobin concentration measured by a HemoCue Hemoglobin B analyzer. A scatter plot, correlation coefficient, Bland and Altman plot, and Area under curve were employed to assess the agreement and acceptability of the calculated Hematocrit as compared to the standard Micro-hematocrit. Result The correlation coefficient, Intraclass correlation coefficient and concordance correlation coefficient were 0.91, 0.94, and 0.89, respectively. The Bland and Altman plot showed a mean difference of 0.94 with the limit of agreement ranges from 0.6 to 1.3. The area under the receiver operating characteristics with cut-off point of Hematocrit <33% was 0.86. The sensitivity and specificity of the calculated method was 95.5% and 71.4%, respectively. Conclusion Generally there is excellent association between the two methods. The two methods were identical within inherent imprecision of both methods. Hence, the Hematocrit value, threefold calculated from the Hemoglobin was found to be acceptable to diagnose anemia in pregnant women.

Consumptive Coagulopathy Involving Amniotic Fluid Embolism: The Importance of Earlier Assessments for Interventions in Critical Care

“…In the present study, we focused on the discrepancy between the hemoglobin and fibrinogen levels at the onset of AFE according to the following reasons. First, coagulopathy of AFE potentially developed systemic hemorrhage, which resultantly led to anemia; however, the patient’s hemoglobin concentration was often maintained before bleeding and/or even immediately after acute hemorrhage, as previously reported ( 18 , 19 ). Second, on the other hand, fibrinogen levels in AFE frequently decreased in a remarkably short length of time from the onset ( 20 ).…”

EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)

“…In order to prevent misclassification as much as possible, we recommend correcting for hematocrit. If this is not possible, a COI value of <0.2 in the ECLIA or a S/C value <0.22 in the IgG and IgA ELISAs regardless of the hematocrit result would, with a high probability, correspond to a negative result in serum, even in patients with anemia (not lower than a hematocrit of 20%, which corresponds to a hemoglobin level of 67 g/L using the rule of three for converting hematocrit into hemoglobin levels [24]).…”

Point-of-care testing of plasma free hemoglobin and hematocrit for mechanical circulatory support

“…Therefore, we used the Hct method to calculate the hemoglobin level (Eq. 3): 27 Standard curve for the quantification of plasma color. The method to measure the level of PFHb is based on the phenomenon that as the hemolysis becomes more severe, the redness of the color of plasma increases.…”